Article Details
Retrieved on: 2021-06-17 20:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, is raising its guidance for 2021, following the ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here